Common Stock, Shares, Outstanding of Solid Biosciences Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Solid Biosciences Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Solid Biosciences Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 77,882,685, a 100% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Solid Biosciences Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 77,882,685 +38,952,482 +100% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 77,602,741 +39,051,682 +101% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 77,492,959 +39,659,270 +105% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 40,468,141 +20,081,535 +99% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 38,930,203 +18,868,452 +94% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 38,551,059 +18,506,670 +92% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 37,833,689 +18,260,557 +93% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 20,386,606 +829,874 +4.2% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 20,061,751 +12,528,670 +166% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 20,044,389 -92,920,309 -82% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 19,573,132 -93,208,159 -83% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 19,556,732 +12,200,715 +166% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 7,533,081 -102,762,519 -93% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 112,964,698 +2,668,706 +2.4% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 112,781,291 +2,492,724 +2.3% 31 Mar 2022 10-Q 27 Apr 2022 2022 Q1
Q4 2021 7,356,017 -77,537,977 -91% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 110,295,600 +64,117,081 +139% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 110,295,992 +64,308,421 +140% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 110,288,567 +64,217,843 +139% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 84,893,994 +38,906,423 +85% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 46,178,519 +179,575 +0.39% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 45,987,571 +10,588,677 +30% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 46,070,724 +10,655,810 +30% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 45,987,571 +10,555,111 +30% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 45,998,944 +10,566,484 +30% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 35,398,894 -45,898 -0.13% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 35,414,914 -61,978 -0.18% 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 35,432,460 +35,432,460 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 35,432,460 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 35,444,792 30 Jun 2018 10-Q 10 Aug 2018 2018 Q2
Q1 2018 35,476,892 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 0 31 Dec 2017 10-K 13 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.